Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boiled Peanut OIT in Peanut Allergic Children
NCT04090203Phase 1Completed
- Start
- Nov 2019
- Primary completion
- May 2021
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of boiled peanut powder in Peanut allergy. Primary endpoint: Percentage of Participants Successfully Desensitized at 18 weeks. Started Nov 2019; status: completed.
02
Drugs
boiled peanut powder
03
Conditions
Peanut allergy
Beyond the preview
Go deeper on NCT04090203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04090203.